BCBSNC Names Lisa Carey to Board of Trustees

Blue Cross and Blue Shield of North Carolina (BCBSNC) has named Lisa Carey, M.D., to its board of trustees. Carey is medical director of the UNC Breast Center, associate director of UNC Lineberger Comprehensive Cancer Center and a member of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute. BCBSNC’s board consists of community leaders across North Carolina with varied backgrounds in health care, education, business and finance.

“Lisa’s years of experience in clinical research and deep knowledge of the health care industry make her an excellent addition to our board,” said Brad Wilson, BCBSNC’s president and CEO. “Along with her notable medical accomplishments, Lisa is a leader in her community and is devoted to improving the lives of North Carolinians. These strengths will benefit our company and our customers.”

A member of UNC’s faculty since 1998, Carey is a leading figure in North Carolina’s breast cancer research efforts. She and colleagues at UNC have written widely on racial disparities in breast cancer development and mortality, and she has led multiple clinical trials, in North Carolina and nationally, investigating new drugs and approaches in breast cancer. Carey also serves on several national cancer committees, such as the National Cancer Institute (NCI)’s Breast Cancer Steering Committee. She was awarded a Doris Duke Clinician Scientist Award in 1999, a Career Development Award from the National Cancer Institute in 2000, was inducted into Johns Hopkins Society of Scholars in 2008, and received the NCI Director’s Service Award in 2011.

Carey attended Wellesley College, and received her M.D. from the Johns Hopkins School of Medicine. She completed her residency and fellowship in medical oncology at Johns Hopkins.